AiCure

Recipharm

Recipharm acquires Lusomedicamenta

Friday, November 14, 2014 02:21 PM

Recipharm, a Swedish pharmaceutical contract development and manufacturing organization (CDMO), has acquired Lisbon, Portugal-based CDMO Lusomedicamenta Sociedade Técnica Farmacêutica.

More... »


Recipharm to acquire Corvette Pharmaceutical Services Group for $159.4M

Wednesday, August 20, 2014 01:15 PM

Recipharm, a Sweden-based contract development and manufacturing organization, has signed an agreement to acquire Milan-based Corvette Pharmaceutical Services Group from Italian private equity group LBO Italia Investimenti.

More... »


Recipharm, CTC form new collaboration

Thursday, June 19, 2014 01:49 PM

CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development have entered into a collaboration.

More... »

Recipharm, Synthonics to promote novel drug delivery technology

Wednesday, May 8, 2013 09:40 AM

Recipharm Pharmaceutical, a Swedish contract development and manufacturing organization (CDMO), and Synthonics, a specialty pharmaceutical company based in Blacksburg, Va., have formed a Joint Promotion Agreement.

More... »

Recipharm appoints Lennernäs to operating board

Wednesday, February 6, 2013 12:38 PM

Recipharm, a contract development and manufacturing organization based in Sweden, has appointed Dr. Hans Lennernäs to the operating board of Recipharm Pharmaceutical Development.

More... »

Recipharm invests in analytical development services

Monday, December 10, 2012 11:27 AM

Recipharm, a contract development and manufacturing organization based in Sweden, has invested in expanding its capacity in analytical services and stability studies at its facility in Solna, Sweden.

More... »

Recipharm, Astimex form development and manufacturing collaboration

Friday, October 12, 2012 11:58 AM

Recipharm, a Swedish contract development and manufacturing organization, and Astimex Pharma, a Swedish pharmaceutical company, have formed a collaboration agreement for the development and manufacture of a pharmaceutical product.

More... »

Recipharm secures financing for future growth

Friday, May 25, 2012 11:32 AM

Recipharm, an international pharmaceutical contract development and manufacturing organization, has arranged a five-year $113 million loan facility with Swedbank, one of the largest banks in Sweden.

More... »

ViroPharma contracts Recipharm to manufacture Plenadren

Monday, March 19, 2012 09:56 AM

Recipharm, the international contract pharmaceutical development and manufacturing organization, has been contracted by ViroPharma to complete commercial scale-up manufacture of Plenadren (hydrocortisone), used for the treatment of adrenal insufficiency in adults.

More... »

RecipharmCobra Biologics names commercial director

Monday, August 1, 2011 12:29 PM

RecipharmCobra Biologics, the international manufacturer of biopharmaceuticals, has named Julian Hanak its commercial director. Julian will join the RecipharmCobra management team to build on the company’s growth in provision of manufacturing services for the biotech and biopharmaceutical industry.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs